Selective laser trabeculoplasty (SLT) has been proven to slow the progression of existing glaucoma disease by lowering pressure inside the eye.

People living with retinitis pigmentosa (RP) may one day benefit from a new drug being trialled in Australia.

The world’s first Myopia Action Month is taking place this month, with the aim to turn myopia awareness into action. A concept developed by

Eyetelligence, an Australian-based leading innovator in AI-powered healthcare solutions, will showcase its cutting-edge eye screening software at O=MEGA23 in Melbourne from 7 – 9